Answers are grounded in this paper and cite their sources.
Parenteral nutrition is essential for treating disease-related malnutrition, a common issue among hospitalized patients. Combinations of water-soluble and lipid-soluble vitamins function as macronutrient cofactors and must be administered concomitantly with parenteral nutrition. However, off-labeled use of these intravenous multivitamins is frequent, often offering no demonstrated clinical benefit to patients. We aimed to assess the impact of a multifaceted intervention designed to optimize these multivitamins prescribing practices. The multifaceted intervention comprised guideline development, an information mailing, integration into the clinical decision support system, pharmacy inventory management, mandatory pharmaceutical validation prior to drug dispensing, and collaboration with the Nutrition Unit. We conducted an interrupted time series study to assess changes in levels and/or trend of multivitamin consumption. During the intervention period, all hospitalized patients admitted for more than 24 h with a multivitamin prescription were assessed to determine whether their orders adhered to the updated recommendations. During the intervention period, a total of 361 distinct medical prescriptions were analyzed. Overall, 71.5% of initial multivitamin prescriptions adhered to the recommendations, with the majority associated with central parenteral nutrition. Time series analysis revealed that the intervention was associated with a dramatic reduction in monthly intravenous multivitamin per 10,000 hospitalized patients. Mean consumption dropped from 8423 ± 2462.5 units/month pre-intervention to 391 ± 255.1 units/month post-intervention, corresponding to a 97.2% reduction in the predicted versus observed number of dispensed units (RR: 0.028 [CI 95% : 0.025 to 0.031]). A multifaceted stewardship intervention based on a restrictive prescribing policy was highly effective, achieving a dramatic and sustained reduction in intravenous multivitamin consumption and substantial direct cost savings. Oral substitution successfully targeted off-label use in non-parenteral nutrition patients while maintaining intravenous therapy where indicated. Such interventions eliminate low-value prescribing and provide a scalable strategy during drug shortages.
No takes yet. Share an insight, caveat, or question.
Berdot et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: